Hypera S.A. (HYPE3.SA)
BRL 16.8
(-5.46%)
BRL 16.8
(-5.46%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 1.64 Billion BRL | -2.87% |
| 2022 | 1.69 Billion BRL | 27.55% |
| 2021 | 1.33 Billion BRL | 2.71% |
| 2020 | 1.29 Billion BRL | 11.26% |
| 2019 | 1.16 Billion BRL | 3.05% |
| 2018 | 1.12 Billion BRL | 17.06% |
| 2017 | 964.94 Million BRL | -17.85% |
| 2016 | 1.17 Billion BRL | 109.79% |
| 2015 | 559.87 Million BRL | 39.03% |
| 2014 | 402.69 Million BRL | 56.86% |
| 2013 | 256.72 Million BRL | 25.9% |
| 2012 | 203.91 Million BRL | 473.12% |
| 2011 | -54.65 Million BRL | -120.87% |
| 2010 | 261.9 Million BRL | -16.43% |
| 2009 | 313.37 Million BRL | 250.75% |
| 2008 | -207.87 Million BRL | -593.77% |
| 2007 | 42.1 Million BRL | 1535.88% |
| 2006 | -2.93 Million BRL | -109.46% |
| 2005 | 31 Million BRL | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 392.24 Million BRL | 27.74% |
| 2024 Q2 | 492.81 Million BRL | 25.64% |
| 2023 Q3 | 499.42 Million BRL | -0.72% |
| 2023 Q1 | 338.43 Million BRL | -20.9% |
| 2023 FY | 1.64 Billion BRL | -2.87% |
| 2023 Q2 | 503.03 Million BRL | 48.64% |
| 2023 Q4 | 307.05 Million BRL | -38.52% |
| 2022 Q1 | 347.66 Million BRL | -1.34% |
| 2022 Q2 | 455.78 Million BRL | 31.1% |
| 2022 Q3 | 465.36 Million BRL | 2.1% |
| 2022 Q4 | 427.88 Million BRL | -8.06% |
| 2022 FY | 1.69 Billion BRL | 27.55% |
| 2021 Q3 | 201.7 Million BRL | -57.15% |
| 2021 FY | 1.33 Billion BRL | 2.71% |
| 2021 Q1 | 305.34 Million BRL | -3.02% |
| 2021 Q2 | 470.75 Million BRL | 54.17% |
| 2021 Q4 | 352.39 Million BRL | 74.71% |
| 2020 FY | 1.29 Billion BRL | 11.26% |
| 2020 Q2 | 396.41 Million BRL | 66.41% |
| 2020 Q1 | 238.2 Million BRL | -0.23% |
| 2020 Q4 | 314.86 Million BRL | -8.9% |
| 2020 Q3 | 345.62 Million BRL | -12.81% |
| 2019 Q4 | 238.75 Million BRL | -10.63% |
| 2019 Q1 | 321.18 Million BRL | 3.68% |
| 2019 Q3 | 267.15 Million BRL | -20.71% |
| 2019 Q2 | 336.94 Million BRL | 4.91% |
| 2019 FY | 1.16 Billion BRL | 3.05% |
| 2018 Q3 | 242.27 Million BRL | -12.79% |
| 2018 Q1 | 299.75 Million BRL | -26.74% |
| 2018 FY | 1.12 Billion BRL | 17.06% |
| 2018 Q4 | 309.77 Million BRL | 27.86% |
| 2018 Q2 | 277.79 Million BRL | -7.33% |
| 2017 Q3 | 177.34 Million BRL | -9.03% |
| 2017 Q2 | 194.93 Million BRL | 6.24% |
| 2017 Q1 | 183.48 Million BRL | 186.36% |
| 2017 FY | 964.94 Million BRL | -17.85% |
| 2017 Q4 | 409.17 Million BRL | 130.73% |
| 2016 Q3 | 202.51 Million BRL | 14.8% |
| 2016 FY | 1.17 Billion BRL | 109.79% |
| 2016 Q4 | -212.46 Million BRL | -204.91% |
| 2016 Q2 | 176.4 Million BRL | -82.5% |
| 2016 Q1 | 1 Billion BRL | 256.27% |
| 2015 Q2 | 110.85 Million BRL | 22.26% |
| 2015 Q3 | 75.38 Million BRL | -32.0% |
| 2015 Q4 | 282.96 Million BRL | 275.37% |
| 2015 FY | 559.87 Million BRL | 39.03% |
| 2015 Q1 | 90.66 Million BRL | 26.82% |
| 2014 Q1 | 90.23 Million BRL | 64.31% |
| 2014 Q4 | 71.49 Million BRL | -39.81% |
| 2014 Q3 | 118.77 Million BRL | -2.79% |
| 2014 FY | 402.69 Million BRL | 56.86% |
| 2014 Q2 | 122.18 Million BRL | 35.41% |
| 2013 Q3 | 80.18 Million BRL | 315.22% |
| 2013 Q2 | 19.31 Million BRL | -81.13% |
| 2013 Q1 | 102.31 Million BRL | -17.93% |
| 2013 FY | 256.72 Million BRL | 25.9% |
| 2013 Q4 | 54.91 Million BRL | -31.51% |
| 2012 Q4 | 124.66 Million BRL | 82.3% |
| 2012 Q1 | 40.8 Million BRL | -17.7% |
| 2012 Q2 | -29.94 Million BRL | -173.37% |
| 2012 Q3 | 68.38 Million BRL | 328.4% |
| 2012 FY | 203.91 Million BRL | 473.12% |
| 2011 Q4 | 49.58 Million BRL | 126.03% |
| 2011 Q1 | 32.93 Million BRL | -50.85% |
| 2011 FY | -54.65 Million BRL | -120.87% |
| 2011 Q2 | 53.29 Million BRL | 61.79% |
| 2011 Q3 | -190.46 Million BRL | -457.4% |
| 2010 FY | 261.9 Million BRL | -16.43% |
| 2010 Q3 | 79.55 Million BRL | 49.38% |
| 2010 Q2 | 53.26 Million BRL | -3.49% |
| 2010 Q4 | 67.01 Million BRL | -15.76% |
| 2010 Q1 | 55.18 Million BRL | -45.34% |
| 2009 Q2 | 132.27 Million BRL | 72.34% |
| 2009 Q1 | 76.74 Million BRL | 0.0% |
| 2009 FY | 313.37 Million BRL | 250.75% |
| 2009 Q4 | 100.96 Million BRL | 2534.02% |
| 2009 Q3 | 3.83 Million BRL | -97.1% |
| 2008 FY | -207.87 Million BRL | -593.77% |
| 2007 FY | 42.1 Million BRL | 1535.88% |
| 2006 FY | -2.93 Million BRL | -109.46% |
| 2005 FY | 31 Million BRL | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Blau Farmacêutica S.A. | 249.8 Million BRL | -559.688% |